95 results
Page 3 of 5
8-K
EX-99.1
l0skpmz5x
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
424B5
mkf19mc
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
m0b4rkh sfd
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K
w244z3uajpunyhva
1 Apr 20
Regulation FD Disclosure
4:39pm
8-K
kw5wwp2hyxo5j nxuhj
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
8-K
6xlv 9yreoz3c0mypn2
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.2
uw3 attt6s5g
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
w4d03ugp0rb
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
t4887e40
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K
pbzplx0
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K
EX-99.1
gs7di6vnp k0kpa9
6 Nov 19
Invitae Reports $56.5 Million in Quarterly Revenue Driven by 129,000 Samples
4:08pm
8-K
EX-99.1
4jtj7pu1oe0vh90pimw
6 Aug 19
Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume
4:17pm